Sea-spray deposition in Antarctic coastal and plateau areas from ITASE traverses

AbstractSea-salt markers (Na+, Mg2+ and Cl–) were analyzed in recent snow collected at more than 600 sites located in coastal and central areas of East Antarctica (northern Victoria Land–Dome C–Wilkes Land), in order to understand the effect of site remoteness, transport efficiency and depositional and post-depositional processes on the spatial distribution of the primary marine aerosol. Firn-core, snow-pit and 1m integrated superficial snow samples were collected in the framework of the International Trans-Antarctic Scientific Expeditions (ITASE) project during recent Italian Antarctic Campaigns (1992–2002). The sampling sites were mainly distributed along coast–inland traverses (northern Victoria Land– Dome C) and an east–west transect following the 2100m contour line (Wilkes Land). At each site, the snow ionic composition was determined. Here, we discuss the distribution of sea-spray components (Na+, Mg2+ and Cl–) as a function of distance from the sea, altitude and accumulation rate, in order to discover the pulling-down rate, possible fractionating phenomena and alternative sources moving inland from coastal areas. Sea-spray depositional fluxes decrease as a function of distance from the sea and altitude. A two-order-of-magnitude decrease occurs in the first 200km from the sea, corresponding to about 2000ma.s.l. Correlations of Mg2+ and Cl– with Na+ and trends of Mg2+/Na+ and Cl–/Na+ ratios showed that chloride has other sources than sea spray (HCl) and is affected by post-depositional processes. Accumulation rate higher than 80 kgm–2 a–1 preserves the chloride record in the snow. Sea-spray atmospheric scavenging is dominated by wet deposition in coastal and inland sites

La protezione dei dati personali nel mondo del lavoro al tempo del web

Questo lavoro si propone di analizzare lo status del diritto in Italia, relativamente alla protezione dei dati personali, al tempo dell'avvento della Rivoluzione 4.0. La privacy, in ogni ambito, rischia di essere minacciata e violata. Di questa istanza si è fatto carico il Parlamento europeo che ha emanato il GDPR poi recepito dalla legislazione italiana con un Decreto di adeguamento. Attraverso l'analisi del GDPR si è proceduto ad evidenziare le novità introdotte ed i limiti ancora presenti nella suddetta legislazione

Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study

Background: Understanding how patients generate preferences for administration route alternatives may improve health-care delivery and clinical outcomes. Recently, novel biological therapies with subcutaneous (SC) and intravenous (IV) administration routes have been approved for severe uncontrolled asthma. The aim of our study was to assess the preferred route of biologic therapy administration and related beliefs among patients with severe uncontrolled asthma. Methods: We conducted a cross-sectional observational survey study. Patients answered an anonymous, self-administered questionnaire after an outpatient visit in pulmonary disease clinics located throughout Italy. Socio-demographic and clinical information together with the 12-Item Short Form Survey (SF-12), Work Productivity Impairment Scale and the medical resources utilization module of the Health & Work Survey were collected. Patients beliefs and preference towards SC and IV administration were investigated by means of an ad hoc 13 item questionnaire. Results: the main findings: 150 patients fulfilled the inclusion criteria and completed the questionnaire (47.3% males). Preference for IV and SC administration was 18.7% and 81.3%, respectively. Compared with patients preferring SC formulation, patients that favored IV were older (p ​= ​0.04), less likely to escalate corticosteroid dose (p ​= ​0.03) and had emergency room (ER) access (p ​= ​0.009) during asthma exacerbations. Patients felt that SC was more convenient than IV, but this belief was not associated with higher likelihood of preferring SC administration. IV formulations were more likely associated with quicker and more effective drug action (p ​= ​0.0001), procedural safety and medical oversight (p ​= ​0.0002) and social support (p ​= ​0.007). Predictors of IV preference were represented by the association of worse asthma control and increased use of ER services, and by beliefs toward formulation effectiveness/efficiency in reducing symptoms (p ​= ​0.04 and p ​< ​0.0001, respectively). The model achieved excellent discrimination of administration route preference (area under the curve ​= ​0.87). Conclusions: Preference is guided by partially misleading beliefs, which may generate wrong expectations that in turn can affect treatment satisfaction and adherence. Convenience and efficacy beliefs for drugs with different routes of administration always should be discussed with patients to achieve informed shared-decision making. Trial registration: Not applicable. Keywords: Subcutaneous, Intravenous, Administration, Severe asthma, Biologic therapy, Preference, Belief, Shared decision makin